The 9th Obesity & NASH Drug Development Summit is dedicated to Non-Alcoholic Steatohepatitis challenges from drug discovery to late stage clinical development.
Topics
Validation of non-invasive biomarker approaches and technologies to more robustly diagnose and track disease progression
How to optimize recapitulation of human NASH in vivo and effectively translate into the clinic
Clinical primary and secondary endpoints and road-map for regulatory path to approval
Ways to improve drug efficacy in both early and late stage NASH by identifying and validating novel targets and drug mechanisms of action
Join your peers in Cambridge, MA, to overcome the challenges that are preventing you from accelerating the development of your NASH candidate
